We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$485M
AUM Growth
+$32.9M
Cap. Flow
+$7.9B
Cap. Flow %
1,627.32%
Top 10 Hldgs %
29.7%
Holding
511
New
21
Increased
215
Reduced
111
Closed
140
Avg Time Held
9.7 quarters
Top 10 Avg Time Held
10.2 quarters
Top 20 Avg Time Held
9.5 quarters

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$7.87B
2
GD icon
General Dynamics
GD
+$18.3M
3
GSK icon
GSK
GSK
+$15.4M
4
CLX icon
Clorox
CLX
+$3.3M
5
MA icon
Mastercard
MA
+$1.51M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$950K
2
ORCL icon
Oracle
ORCL
+$859K
3
FISV icon
Fiserv Inc
FISV
+$824K
4
HON icon
Honeywell
HON
+$781K
5
CELG
Celgene Corp
CELG
+$779K

Sector Composition

Rank Sector Weight
1 Technology 18.71%
2 Consumer Staples 13.04%
3 Financials 12.7%
4 Healthcare 12.3%
5 Communication Services 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LUMN icon
326
Lumen Technologies, Inc. Common Stock
LUMN
$5.45B
$155K 0.03%
10,563
-3,276
-24% -$43.9K
2019 Q3
1 quarter
LYG icon
327
Lloyds Banking Group
LYG
$77.6B
$153K 0.03%
50,514
+4,704
+10% +$14.2K
2018 Q2
6 quarters
KZIA icon
328
Kazia Therapeutics
KZIA
$139M
$142K 0.03%
649
– –
2019 Q3
1 quarter
ACB icon
329
Aurora Cannabis
ACB
$284M
$139K 0.03%
578
-4
-0.7% -$1.49K
2018 Q4
4 quarters
AMAG
330
DELISTED
AMAG Pharmaceuticals
AMAG
$133K 0.03%
11,633
-115
-1% -$1.26K
2019 Q2
2 quarters
BCS icon
331
Barclays
BCS
$76.6B
$116K 0.02%
12,861
-4,531
-26% -$39.1K
2016 Q3
13 quarters
ENIA
332
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$114K 0.02%
13,712
-165
-1% -$1.64K
2018 Q3
5 quarters
TESO
333
DELISTED
Tesco Corp
TESO
$109K 0.02%
11,476
-533
-4% -$5.06K
2018 Q2
6 quarters
NYMX
334
DELISTED
Nymox Pharmaceutical Corp
NYMX
$102K 0.02%
+34,000
New +$67.1K
2019 Q4
0 quarters
SAN icon
335
Banco Santander
SAN
$195B
$100K 0.02%
26,509
-282
-1% -$1.09K
2018 Q2
6 quarters
DVAX icon
336
DELISTED
Dynavax Technologies
DVAX
$77K 0.02%
12,700
+247
+2% +$1.32K
2019 Q2
2 quarters
AKS
337
DELISTED
AK Steel Holding Corp
AKS
$72K 0.01%
24,213
– –
2019 Q1
3 quarters
FON
338
DELISTED
SPRINT CORP FON COM
FON
$64K 0.01%
13,019
-43
-0.3% -$211
2019 Q2
2 quarters
CVIA
339
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$60K 0.01%
32,089
– –
2019 Q3
1 quarter
NOK icon
340
Nokia
NOK
$58B
$57K 0.01%
+13,895
New +$54.6K
2019 Q4
0 quarters
PRTK
341
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$53K 0.01%
14,772
– –
2019 Q2
2 quarters
PTE
342
DELISTED
PolarityTE, Inc. Common Stock
PTE
$53K 0.01%
+544
New +$39.2K
2019 Q4
0 quarters
FNM
343
DELISTED
FANNIE MAE
FNM
$44K 0.01%
13,902
– –
2018 Q3
5 quarters
SND icon
344
Smart Sand
SND
$224M
$30K 0.01%
+14,112
New +$34.9K
2019 Q4
0 quarters
AMPE
345
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$29K 0.01%
146
– –
2019 Q2
2 quarters
ACOR
346
DELISTED
Acorda Therapeutics
ACOR
$20K ﹤0.01%
86
-1
-1% -$252
2019 Q2
2 quarters
CHK icon
347
DELISTED
Chesapeake Energy Corporation
CHK
$7K ﹤0.01%
62
– –
2018 Q2
6 quarters
ADI icon
348
Analog Devices
ADI
$197B
– –
-1,073
Closed -$121K –
ADM icon
349
Archer Daniels Midland
ADM
$38.5B
– –
-3,346
Closed -$144K –
AIG icon
350
American International
AIG
$40.3B
– –
-16,999
Closed -$950K –
12 13
14
15 16

Similar funds

FMC
First Merchants Corp Muncie, Indiana $2.84B AUM 15.58% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.84B AUM
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return
BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $2.83B AUM 14.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

HighPoint Advisor Group's Q4 2019 Portfolio in Review

As of Q4 2019, HighPoint Advisor Group held 511 positions worth $485M, up 7.3% from $452M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

HighPoint Advisor Group deployed $7.9B of net new capital in Q4 2019, opening 21 new positions and adding to 215 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 3,195 shares worth $747K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Oracle, an estimated $859K trimmed.

  • HighPoint Advisor Group's largest Q4 2019 buy was Vertex Pharmaceuticals: 3,195 shares worth $747K.
  • HighPoint Advisor Group added most to Berkshire Hathaway Class A in Q4 2019, an estimated $7.87B increase.
  • HighPoint Advisor Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $859K.
  • HighPoint Advisor Group fully exited American International in Q4 2019, selling an estimated $950K.
  • HighPoint Advisor Group's ten largest holdings make up 30% of its $485M portfolio in Q4 2019.
  • HighPoint Advisor Group opened 21 new positions and closed 140 in Q4 2019.
  • HighPoint Advisor Group's portfolio value rose 7.3% quarter-over-quarter to $485M.

Based on HighPoint Advisor Group's 13F filing for Q4 2019, filed 13 Feb 2020.